Can intermittent fasting improve non-alcoholic fatty liver disease?

Does intermittent fasting actually reduce liver fat and improve liver health in NAFLD?

Yes, multiple randomized controlled trials and meta-analyses show that intermittent fasting (IF) reduces liver fat content and improves liver enzymes in people with NAFLD. The most direct evidence comes from a 3-month randomized trial of 80 adults with obesity and NAFLD: those who followed alternate-day fasting (a 'fast day' of 600 calories alternated with a normal eating day) combined with aerobic exercise saw their liver fat drop by 5.5% — significantly more than the exercise-only group (1.3% reduction) and the control group (0.2% reduction) [1]. The fasting-only group also improved, but the difference between fasting alone and the combination was not statistically significant, meaning fasting alone still helps.

A second randomized trial tested the 5:2 diet (5 days of normal eating, 2 consecutive fasting days) over 12 weeks in 44 patients. The fasting group lost about 3.7 kg (8 pounds), and their liver fat score (measured by ultrasound) dropped from 313 to 290 dB/m — a meaningful reduction [2]. Liver enzymes (ALT and AST) also fell significantly, by about 13 U/L and 8 U/L respectively [2]. These findings are reinforced by a meta-analysis of 7 randomized trials (published up to 2023) which found that IF reduced liver steatosis scores by an average of 33 CAP dB/m, lowered ALT by 9 U/L, and reduced triglycerides by 21 mg/dL [3]. Another meta-analysis of 10 studies (840 participants) confirmed improvements in liver fat and liver stiffness (a marker of fibrosis) after IF [4].

How does intermittent fasting help NAFLD, and what results can you realistically expect?

The primary driver of improvement appears to be weight loss. In the 5:2 diet trial, participants lost about 4% of their body weight, and in the alternate-day fasting trial, the combination group lost significant weight and fat mass [1][2]. The meta-analyses confirm that IF reduces body weight by about 3 kg and waist circumference by about 2 cm on average [3][4]. This weight loss directly reduces the fat stored in the liver. Additionally, IF may improve insulin sensitivity — one trial found a significant increase in insulin sensitivity in the fasting-plus-exercise group [1] — and lower inflammation, as shown by reduced C-reactive protein levels in the 5:2 diet study [2].

However, the improvements are not universal. Liver fibrosis (scarring) did not improve significantly in most studies [1][3][4]. Also, not all blood markers improved: fasting blood sugar, insulin, and 'bad' LDL cholesterol often did not change [2][3]. So while IF can reduce liver fat and improve liver enzymes, it is not a cure-all — especially if liver damage has already progressed to fibrosis. The effects are also modest: a 5% reduction in liver fat is meaningful, but it may take several months of consistent fasting to see results.

What are the limitations and practical considerations?

The evidence, while promising, comes from relatively short studies (2–3 months) with small sample sizes. The largest meta-analysis included only 840 participants across 10 studies [4]. Long-term safety and effectiveness beyond 6 months are not yet established. Also, the type of fasting matters: the studies tested alternate-day fasting, the 5:2 diet, and time-restricted eating (e.g., 16:8), but no single method has been proven superior [3][4]. Importantly, IF did not improve sleep quality or obstructive sleep apnea risk in one trial [5], so it should not be expected to address all NAFLD-related issues.

For someone considering IF for NAFLD, the practical takeaway is: combine it with aerobic exercise for the best results (the combination group in the trial had the largest liver fat reduction) [1], and expect gradual weight loss of about 3–4 kg over 3 months. IF is not a substitute for medical supervision — NAFLD should be managed with a doctor's guidance, especially if you have diabetes or other conditions. Also, avoid fast food, which is strongly linked to NAFLD risk (a 2025 meta-analysis of 169,771 people found a 55% increased risk with higher fast food intake) [6].

About These Sources

This answer is built on 6 peer-reviewed studies — published from 2022 to 2025, 1 from 2024 or later, 4 in Q1 journals, collectively cited 286 times — selected as the most relevant from 7 studies that passed quality screening, drawn from 43 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions